Plus Therapeutics (PSTV) Misses Q4 EPS by 424c
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Jack Henry (JKHY) Tops Q4 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
